OncLive | Bringing the Global Oncology Community Together

Michael Wang, MD, provides insight on recent advances in mantle cell lymphoma as well as research efforts for patients with a high risk of relapse. Read More >>

Selective Inhibitors of Rare Mutations Show Encouraging Activity in NSCLC

Debate Continues Between Upfront Surgery and Neoadjuvant Chemo in Advanced Ovarian Cancer

New Data Change Management of Frontline Metastatic Renal Cell Carcinoma

FDA Approval Sought for Enfortumab Vedotin for Urothelial Cancer

Unanswered Questions Remain in Frontline NSCLC

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

Dr. Norden on Differences Between mCODE and Cota's CNA Network

Dr. Papadimitrakopoulou on Benefits of Liquid Biopsy Versus Standard Tissue in Lung Cancer

Dr. Choueiri on the Next Generation of Trials in RCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Concurrent vs Sequential Rituximab in HCL

HCL Combination Therapy: Rituximab and Purine Analog

IDEA Collaboration; Impact on Adjuvant Therapy

$Emerging Therapies for Relapsed/Refractory Multiple Myeloma$

Newly Diagnosed Myeloma: Transplant Ineligibility and Treatment

Introduction and Overview of the MONALEESA-7 Trial

OncLive houses thousands of videos that provide updates and information.
See more Videos

Safety/Efficacy Experience With Ramucirumab in HCC

VEGF-Targeted Therapy in HCC: Ramucirumab

Frontline-Therapy Decision Factors for mCRC

Approval-Inciting Data in Hepatocellular Carcinoma

Selecting Second-Line Therapy in Hepatocellular Carcinoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates

Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL).

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

FDA Approvals in Myeloma and ITP, Applications Accepted in Myeloma and More